SCHEMBL27419994

SCHEMBL27419994

COC(=O)C1CC/C=C\CC(c2ccccc2)C(NC(=O)OC(C)(C)C)C(=O)N1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 2/20 0.44
▸ MAOB P27338 1/20 0.44
▸ BRD9 Q9H8M2 1/20 0.35
▸ SLC6A3 Q01959 4/20 0.35
▸ SLC6A4 P31645 3/20 0.35
▸ EPHX2 P34913 1/20 0.35
▸ KMT2A Q03164 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ SLC6A2 P23975 2/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34
▸ PDE4B Q07343 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27419831 0.80 KDM1A (0.40) KDM1AMAOBBRD9EPHX2KMT2A
SCHEMBL27419986 0.78 GAA (0.46) KDM1AMAOBEPHX2NFKB1NFKB2
SCHEMBL27419914 0.76 GAA (0.44) EPHX2NFKB1NFKB2RELA
SCHEMBL27420079 0.73 MEN1 (0.44) KDM1AMAOBBRD9KMT2APDE4B
SCHEMBL27419842 0.72 MEN1 (0.46) SLC6A3SLC6A4KMT2AMEN1
SCHEMBL27419818 0.71 GAA (0.48) KDM1AEPHX2NFKB1NFKB2RELA
SCHEMBL14771818 0.66 KDM1A (0.52) KDM1AMAOBEPHX2KMT2AL3MBTL1
SCHEMBL16253593 0.66 KDM1A (0.52) KDM1AMAOBEPHX2KMT2AL3MBTL1
SCHEMBL14771803 0.66 KDM1A (0.52) KDM1AMAOBEPHX2KMT2AL3MBTL1
SCHEMBL16253592 0.66 KDM1A (0.52) KDM1AMAOBEPHX2KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024092256-A2 PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS EISAI R&D MANAGEMENT CO., LTD. (JP) 2024-05-02 — — WO disclosed
Send feedback